BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38792487)

  • 1. Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass.
    Serraino GF; Bolignano D; Jiritano F; Coppolino G; Napolitano D; Zicarelli M; Pizzini P; Cutrupi S; Testa A; Spoto B; Andreucci M; Mastroroberto P; Serra R
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792487
    [No Abstract]   [Full Text] [Related]  

  • 2. High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery.
    Kocak EF; Kocak C; Aksoy A; Isiklar OO; Akcilar R; Ozdomanic IF; Unsal C; Celenk M; Altuntas I
    Cardiovasc J Afr; 2015; 26(6):234-41. PubMed ID: 26212819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative myocardial cell damage in patients with unstable angina undergoing coronary artery bypass graft surgery.
    Mächler H; Metzler H; Sabin K; Anelli-Monti M; Rehak P; Rigler B; Gombotz H
    Anesthesiology; 1994 Dec; 81(6):1324-31. PubMed ID: 7992899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic derangement and cardiac injury early after reperfusion following intermittent cross-clamp fibrillation in patients undergoing coronary artery bypass graft surgery using conventional or miniaturized cardiopulmonary bypass.
    Nguyen BA; Suleiman MS; Anderson JR; Evans PC; Fiorentino F; Reeves BC; Angelini GD
    Mol Cell Biochem; 2014 Oct; 395(1-2):167-75. PubMed ID: 24934242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.
    Muehlschlegel JD; Perry TE; Liu KY; Fox AA; Collard CD; Shernan SK; Body SC
    Anesth Analg; 2010 Nov; 111(5):1101-9. PubMed ID: 20457766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass.
    Czerny M; Baumer H; Kilo J; Lassnigg A; Hamwi A; Vukovich T; Wolner E; Grimm M
    Eur J Cardiothorac Surg; 2000 Jun; 17(6):737-42. PubMed ID: 10856869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of postoperative myocardial injury by heart-type fatty acid-binding protein in off-pump coronary artery bypass grafting surgery.
    Carmona P; Mateo E; Montoro A; Alós L; Coret M; Errando CL; Llagunes J; De Andrés J
    Rev Esp Anestesiol Reanim; 2015 Jan; 62(1):3-9. PubMed ID: 24746360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strict thermoregulation attenuates myocardial injury during coronary artery bypass graft surgery as reflected by reduced levels of cardiac-specific troponin I.
    Nesher N; Zisman E; Wolf T; Sharony R; Bolotin G; David M; Uretzky G; Pizov R
    Anesth Analg; 2003 Feb; 96(2):328-35, table of contents. PubMed ID: 12538173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac marker responses to coronary artery bypass graft surgery with cardiopulmonary bypass and aortic cross-clamping.
    Takeda S; Nakanishi K; Ikezaki H; Kim C; Sakamoto A; Tanaka K; Ogawa R
    J Cardiothorac Vasc Anesth; 2002 Aug; 16(4):421-5. PubMed ID: 12154418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term prognostic value of perioperative coronary sinus-derived-serum cardiac troponin-I, creatine kinase-MB, lactate, pyruvate, and lactate-pyruvate ratio in adult patients undergoing open heart surgery.
    Chowdhury UK; Sheil A; Kapoor PM; Narang R; Gharde P; Malik V; Kalaivani M; Chaudhury A
    Ann Card Anaesth; 2016; 19(3):439-53. PubMed ID: 27397448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery.
    Nair S; Iqbal K; Phadke M; Jadhav UE; Khandekar J; Khandeparkar JM
    J Postgrad Med; 2012; 58(1):8-13. PubMed ID: 22387642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
    Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
    Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery.
    Wu Q; Purusram G; Wang H; Yuan R; Xie W; Gui P; Dong N; Yao S
    Br J Clin Pharmacol; 2013 Mar; 75(3):769-78. PubMed ID: 22835079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10.
    Giomarelli P; Scolletta S; Borrelli E; Biagioli B
    Ann Thorac Surg; 2003 Jul; 76(1):117-23. PubMed ID: 12842524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients.
    Fransen EJ; Maessen JG; Hermens WT; Glatz JF; Buurman WA
    Cardiovasc Res; 2000 Mar; 45(4):853-9. PubMed ID: 10728410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection during elective coronary artery bypasses grafting by pretreatment with omega-3 polyunsaturated fatty acids.
    Veljović M; Popadić A; Vukić Z; Ilić R; Trifunović Z; Antunović M; Mandarić V; Tisma S; Marković Z
    Vojnosanit Pregl; 2013 May; 70(5):484-92. PubMed ID: 23789288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytokine resistin correlates with oxidative stress and myocardial injury in patients undergoing cardiac surgery.
    Laurikka A; Vuolteenaho K; Toikkanen V; Rinne T; Leppänen T; Tarkka M; Laurikka J; Moilanen E
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):729-36. PubMed ID: 24482385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery.
    Alyanakian MA; Dehoux M; Chatel D; Seguret C; Desmonts JM; Durand G; Philip I
    J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):288-94. PubMed ID: 9636910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass.
    Madhivathanan PR; Fletcher N; Gaze D; Thomson R; Chandrasekaran V; Al-Subaie N; Valencia O; Sharma V
    Cytokine; 2016 Jul; 83():8-12. PubMed ID: 26999704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
    Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
    BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.